Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samothrace Medical Innovations is a medical technology company focused on developing advanced hemostatic solutions for life-threatening traumatic injuries. The company's primary focus is the development of a novel device designed to control non-compressible torso hemorrhage (NCTH), a leading cause of preventable death on the battlefield and in civilian trauma. Founded by renowned trauma surgeon Dr. John Holcomb, the company leverages deep clinical expertise to address critical gaps in emergency hemorrhage control. Their technology aims to provide rapid, effective stabilization for patients with internal bleeding where traditional pressure or tourniquets cannot be applied.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samothrace Medical Innovations.